Evidence map›Paper›PMID 34630038›Full record

ArticleFrontiers in molecular neuroscience2021

Novel Functional Properties of Missense Mutations in the Glycine Receptor β Subunit in Startle Disease.

Inken Piro, Anna-Lena Eckes, Vikram Babu Kasaragod, Claudia Sommer, Robert J Harvey, Natascha Schaefer, Carmen Villmann

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Role of the Glycine Receptor β Subunit in Synaptic Localization and Pathogenicity in Severe Startle Disease.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  5. Startle Disease: New Molecular Insights into an Old Neurological Disorder.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2023
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Inken PiroDepartment of Neurology, University Hospital Würzburg, Würzburg, Germany.
Anna-Lena EckesInstitute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Vikram Babu KasaragodNeurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.
Claudia SommerDepartment of Neurology, University Hospital Würzburg, Würzburg, Germany.
Robert J HarveySchool of Health and Behavioural Sciences, University of the Sunshine Coast, Maroochydore, QLD, Australia.
Natascha SchaeferInstitute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Carmen VillmannInstitute for Clinical Neurobiology, University Hospital, Julius-Maximilians-University Würzburg, Würzburg, Germany.
Universitätsklinikum Würzburg · DEMRC Laboratory of Molecular Biology · GBSunshine Coast University Hospital · AU

Funding

Medical Research Council G0601585Medical Research Council MC_UP_1201/15
6 · The paper itself

Abstract

Startle disease is a rare disorder associated with mutations in

Indexed as

gephyrinGLRBglycine receptorhyperekplexiastartle disease

Identifiers

PMID34630038
PMCPMC8498107
OpenAlexW3203882536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.